Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Human ANGPTL7, His Tag immobilized on CM5 Chip can bind Human LILRB4, His Tag (Cat. No. LI4-H52H7) with an affinity constant of 4.67 μM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
MK-0482 | MK-0482 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Solid tumours; Leukemia, Myelomonocytic, Chronic; Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
IO-202 | IO-202 | Phase 1 Clinical | Yiming Biomedical Technology (Hangzhou) Co Ltd | Solid tumours; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute | Details |
YTS-104 | LILRB4 STAR-T; YTS-104 | Phase 1 Clinical | Beijing Qingyi Taike Pharmaceutical Technology Co Ltd | Leukemia, Myeloid; Leukemia, Myeloid, Acute | Details |
BND-35 | BND-35; BND35 | Phase 1 Clinical | Biond Biologics Ltd | Solid tumours; Neoplasms | Details |
NGM-831 | NGM-831 | Phase 1 Clinical | Ngm Biopharmaceuticals Inc | Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
anti-ILT3 CAR-T Therapy(Carbiogene) | Phase 1 Clinical | Carbiogene Therapeutics Co Ltd | Leukemia, Myeloid, Acute | Details | |
MK-0482 | MK-0482 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Solid tumours; Leukemia, Myelomonocytic, Chronic; Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
IO-202 | IO-202 | Phase 1 Clinical | Yiming Biomedical Technology (Hangzhou) Co Ltd | Solid tumours; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute | Details |
YTS-104 | LILRB4 STAR-T; YTS-104 | Phase 1 Clinical | Beijing Qingyi Taike Pharmaceutical Technology Co Ltd | Leukemia, Myeloid; Leukemia, Myeloid, Acute | Details |
BND-35 | BND-35; BND35 | Phase 1 Clinical | Biond Biologics Ltd | Solid tumours; Neoplasms | Details |
NGM-831 | NGM-831 | Phase 1 Clinical | Ngm Biopharmaceuticals Inc | Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
anti-ILT3 CAR-T Therapy(Carbiogene) | Phase 1 Clinical | Carbiogene Therapeutics Co Ltd | Leukemia, Myeloid, Acute | Details |
This web search service is supported by Google Inc.